Amanda da Silva Meneses

Amanda da Silva Meneses

Auto-generated profile, based on publicly available information

Amanda da Silva Meneses

Pontificia Univ Catolica Rio Grande Sul PUCRS, Escola Med, Ave Ipiranga 6690, BR-90610000 Porto Alegre, RS, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
CJClovisa Reck de Jesus
Clovisa Reck de Jesus
ARAline Antônia Souto Rosa
Aline Antônia Souto Rosa
AMAmanda da Silva Meneses
Amanda da Silva Meneses
AAAngélica Conzati Agostini
Angélica Conzati Agostini
FMFernanda Bercht Merten
Fernanda Bercht Merten
LPLeonardo Araújo Pinto
Leonardo Araújo Pinto
Objective: The objective of this study is to evaluate the impact of social distancing resulting from COVID-19 in hospitalizations for infections of the upper airways (URTI), such as acute laryngitis, tracheitis, and otitis media in children aged 0 to 9 years in Brazil, considering that they share the same forms of transmission. Methods: Data on hospitalizations for acute airway changes and their complications in children <9 years old were obtained from the Database of the Brazilian Department of Public Health Informatics for the period 2015 to 2020. These data were also analyzed by macroregions of Brazil (North, Northeast, Southeast, South, and Midwest). The effect of the social distancing strategy on the increase of acute laryngitis, tracheitis, otitis media, and mastitis, as absolute and relative reductions, was calculated by analyzing the annual calculation of 2015-2019 vs 2020. Results: All the hospitalizations compared in the Unified Health System (SUS) for laryngitis and acute tracheitis and otitis media decreased, considering all states of Brazil. The largest reduction in hospitalization reduction was in the North, with -94% in 2015-2019 vs 2020 in cases of laryngitis and acute tracheitis, and in the Midwest, with - 85% in 2015-2019 vs 2020 in cases of otitis media. Conclusion: Hospitalizations for laryngitis, acute tracheitis, and acute otitis media in children <9 years old decreased between March and July 2020 in Brazil, when social distancing measures were adopted due to the COVID-19 pandemic.

23 July 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
FFFrederico Friedrich
Frederico Friedrich
LPLucas Montiel Petry
Lucas Montiel Petry
LGLaura de Castro e Garcia
Laura de Castro e Garcia
MPMarina Puerari Pieta
Marina Puerari Pieta
AMAmanda da Silva Meneses
Amanda da Silva Meneses
LPLeonardo Araujo Pinto
Leonardo Araujo Pinto
Objective: Cystic fibrosis (CF) affects multiple organs, the most severe consequences being observed in the lungs. Despite significant progress in developing CF transmembrane conductance regulator-specific treatments for CF lung disease, exploring alternative CF-targeted medications seems reasonable. We sought to evaluate the potential beneficial effects of oral benzbromarone as an adjuvant therapy in CF patients with reduced lung function. Methods: This was a prospective open-label pilot study of oral benzbromarone (100 mg/day) administered once daily for 90 days. Patients were followed at a tertiary referral center in southern Brazil. Safety was assessed by the number of reported adverse events. Secondary objectives included percent predicted FEV1 (FEV1%) and pulmonary exacerbations. Results: Ten patients were enrolled. Benzbromarone was found to be safe, with no serious drug-related adverse events. Eight patients completed the study; the median relative change in FEV1% tended to increase during the treatment, showing an 8% increase from baseline at the final visit. However, a nonparametric test showed that the change was not significant (p = 0.06). Of a total of ten patients, only one experienced at least one pulmonary exacerbation during the study. Conclusions: Oral benzbromarone appears to be safe, and improved FEV1% has been observed in patients with CF. Further assessment in larger trials is warranted to elucidate whether oral benzbromarone can be a potential adjuvant therapy for CF.

27 February 2023 in Scientia Medica
Verified
Journal Article
Open access
PDF file
LPLucas Montiel Petry
Lucas Montiel Petry
LGLaura De Casto e Garcia
Laura De Casto e Garcia
LGLucas Kich Grun
Lucas Kich Grun
AMAmanda Da Silva Meneses
Amanda Da Silva Meneses
LBLuana Braga Bittencourt
Luana Braga Bittencourt
LPLeonardo Araujo Pinto
Leonardo Araujo Pinto
Objetivo: este trabalho tem como objetivo descrever o diagnóstico e o acompanhamento de pacientes acometidos pelas manifestações da fibrose cística e grandes deleções do gene CFTR. Para isso, realizamos análise retrospectiva de prontuários, incluindo genotipagem e acompanhamento retrospectivo de dados clínicos e de função pulmonar. Descrição dos casos: foram avaliados prontuários eletrônicos e impressos de pacientes acompanhados em ambulatório de referência em fibrose cística. Encontramos três pacientes com grandes deleções no gene CFTR, sendo dois deles heterozigotos (heterozigotos com deleção nos éxons de 2 a 3 e heterozigotos para deleções nos éxons de 25 a 27) e um deles homozigoto (homozigoto para as deleções nos éxons de 19 a 21,). Um paciente apresentou resultado falso negativo no sequenciamento genético completo. Todos os três receberam tratamento padrão para fibrose cística. Dois pacientes morreram de complicações pulmonares da fibrose cística. Portanto, achados falsos negativos no sequenciamento CFTR para o diagnóstico de fibrose cística são raros, mas podem ser mais frequentes em pacientes com grandes deleções. Conclusão: grandes deleções de CFTR estão associadas a fenótipos graves de FC.